Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

Fernand Bteich,1 Kush Desai,1 Chenxin Zhang,1,2 Anahat Kaur,3 Rachel A Levy,1 Lydia Bioh,1 Aaron Wang,1 Sharmin Sultana,1 Andreas Kaubisch,1 Milan Kinkhabwala,1,4 Sarah Bellemare,1,4 Shabnam Fidvi,5 Devaraju Kanmaniraja,5 Robert Berkenblit,5 Jee-Young Moon,1,2 Adebola Adedimeji,2 Clara Y Tow,6 Yvonn...

Full description

Bibliographic Details
Main Authors: Bteich F, Desai K, Zhang C, Kaur A, Levy RA, Bioh L, Wang A, Sultana S, Kaubisch A, Kinkhabwala M, Bellemare S, Fidvi S, Kanmaniraja D, Berkenblit R, Moon JY, Adedimeji A, Tow CY, Saenger Y
Format: Article
Language:English
Published: Dove Medical Press 2024-02-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
systemic therapy
immunotherapy
checkpoint inhibitors
minorities.
Online Access:https://www.dovepress.com/immunotherapy-efficacy-in-advanced-hepatocellular-carcinoma-in-a-diver-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/immunotherapy-efficacy-in-advanced-hepatocellular-carcinoma-in-a-diver-peer-reviewed-fulltext-article-JHC

Similar Items